Manager, Clinical and Safety Analytics at Bristol-Myers Squibb

Hyderabad, Telangana, India

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, BiotechnologyIndustries

Requirements

Candidates should possess a Bachelor’s degree in a scientific discipline, such as Statistics, Mathematics, Computer Science, or a related field, and have a minimum of 7 years of experience in clinical and/or safety analytics, with a preference for experience in the pharmaceutical industry. Strong analytical and problem-solving skills are essential, along with proficiency in data visualization tools and statistical software.

Responsibilities

The Manager, Clinical and Safety Analytics will be responsible for enhancing and developing a framework related to data analytics reporting utilizing metrics collected within the Worldwide Patient Safety & PV CoE Analytics function. They will enable analytical use of the compliance data to provide insights related to productivity, efficiency, and quality, facilitating informed decision-making for BMS REMS & Clinical Analytics. This includes ensuring compliance with regulatory requirements, maintaining and developing programming, reporting, and analytics applications in BMS environments, leveraging internal data systems and tools, and developing reports regarding activities, outcomes, and trends. The role also involves delivering presentations to management, staying abreast of industry changes, analyzing stakeholder complaints, interpreting analytical findings, and collaborating with cross-functional teams to propose impactful solutions.

Skills

Data Analytics

Reporting

Compliance

Regulatory Requirements

Drug Safety

Qualitative Research

Quantitative Research

Data Visualization

Spotfire

Tableau

Excel

Data Systems

Communication

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free